Paper
0
Inflammatory Biomarkers Predict Response and Survival in Chemotherapy-Ineligible and Untreated Acute Myeloid Leukemia Patients Receiving Venetoclax-Azacytidine As Front-Line Therapy
Authors
Mathilde Bastien,Maxime Jullien
Nicolas Vallet,Aline Schmidt,Tony Marchand,Amandine Bourgeois,Alice Garnier,Sophie Vantyghem,Aude-Marie Fourmont,Corentin Orvain,Marc Bernard,Thierry Guillaume,Jean-Baptiste Méar,Mathilde Hunault,Emmanuel Gyan,Pierre Péterlin,Patrice Chevallier
+15 authors
,Jean‐Baptiste MearJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave